A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186

David A. Macdonald, Sarit E. Assouline, Joseph Brandwein, Suzanne Kamel-Reid, Elizabeth A. Eisenhauer, Stephen Couban, Stephen Caplan, Alison Foo, Wendy Walsh, Brian Leber

Research output: Contribution to journal › Article › peer-review

40 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science